In a world of endless emails and webinar fatigue it sometimes feels difficult to navigate information and find ideas that can truly impact your day-to-day work. Wouldn’t it be great if there was a centralised place you could visit to grab the relevant ideas and content, and even help grow the idea pool by contributing?
With this thought in mind Lab Ideas for Medicine Makers was born. A truly focused collection of ideas, information and real-life experiences shared by community members that have solved real problems and improved their science. Webcasts, application notes and live (and on-demand) panel discussions cover a variety of topics all carefully selected based on feedback from experts – the scientists who make medicines.
“Our lab is outdated but switching LC models or vendors makes my QA/QC lab feel uneasy.”
The Successful Leap of Faith for an Established Chromatography Lab
The first of our featured content discusses the impact of changing instrument suppliers while working in a regulated environment, and the challenges this brings. We talk about a change on a scale that would typically make people in analytical labs very nervous.Making Instrument Equivalency Assessments and Actions Successful
With all-new equipment in the laboratory, our Pharma CDMO services faced many questions from sponsors. We discuss how performance differences can be counterbalanced and productivity improved with due diligence in method transfer and instrument equivalency procedures. As an example, we highlight the case of transferring an existing validated small molecule drug analysis protocol to the Thermo Scientific Vanquish Flex UHPLC system.
Lessons Learned from Transitioning to New Chromatography Instrumentation and Vendors
Pharmaceutical companies have much to consider when changing instrument types or instrument vendors, as this impacts associated qualification and documentation procedures, as well as training activities. Potential benefits, however, for new instrument types or new instrument vendors in Pharmaceutical laboratories include better performance and reliability of the new equipment. In this session, our panelists discuss how to overcome the implementation dip when introducing a new instrument type in a regulated environment.
This rolling and dynamic platform features new topics each month, so be sure to keep visiting for
more great ideas and discussion, such as:
“Being audited is stressful. Are we prepared?”
“Dealing with the ever-changing landscape of impurity analysis?”
Visit Lab Ideas for Medicine Makers to join the journey.
Thermo Fisher Scientific
United States
